Collagenase Biobank Study
ConditionColorectal (Colon or Rectal) Cancer
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Chicago
About this trial
The purpose of this study is to look at how bacteria present within the stool at the time of surgery and postoperatively may contribute to the development of cancer recurrence after surgery. By collecting stool and blood before and after surgery, the researchers hope to determine if certain types of bacteria, or products that the bacteria produce, promote the development of tumors after surgery. By collecting tumor tissue and growing cell lines, we hope this will help researchers better understand the behavior of these types of tumors.
Eligibility criteria
Qualifiers
English speaking.
All genders, races, and ethnicities.
Aged greater or equal to 18 years of age.
Ability to understand and the willingness to sign a written informed consent form.
Disqualifiers
Stage IV colon adenocarcinoma (known metastatic disease).
Intravenous or oral antibiotic exposure within 30 days of surgery to treat an infection.
Prebiotic exposure within 30 days of surgery.
History of neoadjuvant chemotherapy/radiation to treat the primary colon adenocarcinoma.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
University of Chicago
Lead sponsor
University of California, San Diego
Collaborator
Midwestern University
Collaborator
Source ClinicalTrials.gov